EVOLVE Trademark

Trademark Overview


On Friday, March 8, 2024, a trademark application was filed for EVOLVE with the United States Patent and Trademark Office. The USPTO has given the EVOLVE trademark a serial number of 98439946. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, November 18, 2024. This trademark is owned by Mallinckrodt Pharmaceuticals Ireland Limited. The EVOLVE trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations, namely, nitric oxide for inhalation for treating pulmonary hypertension and conditions associated with pulmonary hypertension; Pharmaceutical preparations, namely, inhaled pharmaceutical preparations for treating pulmonary hypertension and conditions associated with pulmonary hypertension.

Apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes, namely, medical and therapeutic gas delivery systems comprised primarily of gas cylinders, valves, regulators, flow meters, delivery hoses and apparatus and instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patients

General Information


Serial Number98439946
Word MarkEVOLVE
Filing DateFriday, March 8, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, November 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 10, 2024

Trademark Statements


Description of MarkThe mark consists of the stylized wording EVOLVE, with all the letters in purple, except for the spiraling letter "O" which is in aqua blue and purple.  The color white is for background purposes only.  It is not part of the mark.
Goods and ServicesPharmaceutical preparations, namely, nitric oxide for inhalation for treating pulmonary hypertension and conditions associated with pulmonary hypertension; Pharmaceutical preparations, namely, inhaled pharmaceutical preparations for treating pulmonary hypertension and conditions associated with pulmonary hypertension.
Indication of Colors claimedThe color(s) aqua blue and purple is/are claimed as a feature of the mark.
Goods and ServicesApparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes, namely, medical and therapeutic gas delivery systems comprised primarily of gas cylinders, valves, regulators, flow meters, delivery hoses and apparatus and instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patients

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 8, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, March 8, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMallinckrodt Pharmaceuticals Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin 15D15TX2V
IE

Trademark Events


Event DateEvent Description
Friday, March 8, 2024NEW APPLICATION ENTERED
Tuesday, July 23, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, July 23, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 20, 2024ASSIGNED TO EXAMINER
Thursday, September 26, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 26, 2024NON-FINAL ACTION WRITTEN
Tuesday, October 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 15, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 26, 2024NON-FINAL ACTION E-MAILED
Wednesday, October 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 13, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 13, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, November 13, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 13, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 13, 2024EXAMINERS AMENDMENT E-MAILED